2017

Brexit and The Pharma and Biotech Industry

The Pharma and Biotech industry is likely to be significantly impacted by Brexit. The joint notice and Q&A document from EMA and European Commission along with the notice from the CMDh in May have provided an indication of the changes that the Pharma and Biotech industry will need to undergo to meet the new landscape. ...Read more


Kinapse announces Dawn Marriott-Sims as its new Executive Chairman

Kinapse today announced the appointment of Dawn Marriott-Sims as its new Executive Chairman. The appointment will be effective 22nd May 2017. This appointment follows the departure of Kurt Brykman, former CEO of Kinapse by mutual consent. The Board would like to thank Kurt for his contribution and wish him well for the future. ...Read more


Advise · Build · Operate